Expert Opinion on Drug Metabolism and Toxicology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Evaluating the risk of toxicity and adverse drug interactions involving recreational GHB use and prescribed drugs
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - January 20, 2022 Category: Drugs & Pharmacology Authors: Giovanna Ricci Francesco Paolo Busard ò Filippo Gibelli Ascanio Sirignano Pietro Brunetti Source Type: research
An evaluation of the pharmacokinetics of inclisiran in the treatment of atherosclerotic cardiovascular disease
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - January 20, 2022 Category: Drugs & Pharmacology Authors: Brian Tomlinson Elaine Chow Paul Chan Christopher Wai Kei Lam Source Type: research
Optimizing therapeutic drug monitoring in inflammatory bowel disease: a focus on therapeutic monoclonal antibodies
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - January 11, 2022 Category: Drugs & Pharmacology Authors: Konstantinos Papamichael Adam S. Cheifetz Source Type: research
The Impact of Pregnancy on Antihypertensive Drug Metabolism and Pharmacokinetics: Current Status and Future Directions
Volume 17, Issue 11, November 2021, Page 1261-1279 . (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - December 10, 2021 Category: Drugs & Pharmacology Authors: Ian R. Mulrenin Julian E. Garcia Muluneh M. Fashe Matthew Shane Loop Melissa A. Daubert Rachel Peragallo Urrutia Craig R. Lee Source Type: research
Cutaneous toxicity of FDA-approved small-molecule kinase inhibitors
Volume 17, Issue 11, November 2021, Page 1311-1325 . (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - November 26, 2021 Category: Drugs & Pharmacology Authors: Jiangxia Du Hao Yan Zhifei Xu Bo Yang Qiaojun He Xiaohong Wang Peihua Luo Source Type: research
Cutaneous toxicity of FDA-approved small-molecule kinase inhibitors
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - November 26, 2021 Category: Drugs & Pharmacology Authors: Jiangxia Du Hao Yan Zhifei Xu Bo Yang Qiaojun He Xiaohong Wang Peihua Luo Source Type: research
Biomarkers of idiosyncratic drug-induced liver injury (DILI) - a systematic review
Volume 17, Issue 11, November 2021, Page 1327-1343 . (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - November 15, 2021 Category: Drugs & Pharmacology Authors: Edmond Atallah Cristiana Freixo Ismael Alvarez-Alvarez F.J Cubero Alexander L. Gerbes Gerd A. Kullak-Ublick Guruprasad P. Aithal Source Type: research
Novel models for the prediction of drug –gene interactions
Volume 17, Issue 11, November 2021, Page 1293-1310 . (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - November 15, 2021 Category: Drugs & Pharmacology Authors: Denise T ürk Laura Maria Fuhr Fatima Zahra Marok Simeon R üdesheim Anna K ühn Dominik Selzer Matthias Schwab Thorsten Lehr Source Type: research
Biomarkers of idiosyncratic drug-induced liver injury (DILI) - a systematic review
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - November 15, 2021 Category: Drugs & Pharmacology Authors: Edmond Atallah Cristiana Freixo Ismael Alvarez-Alvarez F.J Cubero Alexander L. Gerbes Gerd A. Kullak-Ublick Guruprasad P. Aithal Source Type: research
Novel models for the prediction of drug –gene interactions
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - November 15, 2021 Category: Drugs & Pharmacology Authors: Denise T ürk Laura Maria Fuhr Fatima Zahra Marok Simeon R üdesheim Anna K ühn Dominik Selzer Matthias Schwab Thorsten Lehr Source Type: research
A Quantitative Approach to the Prediction of Drug-Drug Interactions Mediated by Cytochrome P450 2C8 Inhibition
Volume 17, Issue 11, November 2021, Page 1345-1352 . (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - November 3, 2021 Category: Drugs & Pharmacology Authors: Veronica Di Paolo Francesco Maria Ferrari Italo Poggesi Luigi Quintieri Source Type: research
Machine learning models in the prediction of drug metabolism: challenges and future perspectives
Volume 17, Issue 11, November 2021, Page 1245-1247 . (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - November 3, 2021 Category: Drugs & Pharmacology Authors: Eleni E. Litsa Payel Das Lydia E. Kavraki Source Type: research
Machine learning models in the prediction of drug metabolism: challenges and future perspectives
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - November 3, 2021 Category: Drugs & Pharmacology Authors: Eleni E. Litsa Payel Das Lydia E. Kavraki Source Type: research